Predictive Values of Maternal Serum Levels of Procalcitonin, ESR, CRP, and WBC in the Diagnosis of Chorioamnionitis in Mothers with Preterm Premature Rupture of Membrane

Authors

1 Urmia University of Medical Sciences, Urmia, Iran

2 Department of pathology, Urmia University of Medical Sciences, Urmia, Iran

3 Specialist of Gynecology, Urmia University of Medical Sciences, Urmia, Iran

Abstract

Background: Premature rupture of membrane (PROM) refers to the rupture of fetal membranes at least 1 hour before the onset of labor pain. We aimed to determine the predictive value of maternal serum level of procalcitonin in the early diagnosis of chorioamnionitis in mothers with preterm (PPROM).
Methods: In this prospective cohort study, 48 patients with PPROM were selected due to limited financial resources and in accordance with previous similar articles. The study was carried out in Kosar ward of Motahhari Hospital of Urmia, Iran. The inclusion criteria were leaking amniotic fluid, positive nitrazine and fern tests, gestational age of 28-33 weeks, and lack of fetal tachycardia. The exclusion criteria were chronic vascular and congenital heart diseases as well as the use of nonsteroidal anti-inflammatory drugs (NSAIDs). To analyze the data, we used descriptive statistics, Chi-square test (OR), independent t-test, and Pearson in SPSS, version 19.
Results: The present study was conducted on 48 pregnant women and their neonates. About 39.6% of the mothers were pathologically infected with chorioamnionitis, while 60.4% of the patients were not infected with the disease. Moreover, 68.8% of the neonates had a five-minute Apgar score of ≥ 7. There was a significant correlation between the mothers’ infection with histopathologic chorioamnionitis and neonatal hospitalization in neonatal intensive care unit (P<0.001).
Conclusion: According to the results, there was a significant correlation between the inflammatory indices of erythrocyte sedimentation rate, C-reactive protein, and white blood cell during the delivery time and histopathologic chorioamnionitis.

Keywords


1. Svigos JM, Dodd JM, Robinson JS. Prelabor rupture of the membranes. James DK, Steer PJ, Weiner CP, Gonik B, editors. High risk pregnancy e-book: management options-expert consult. New York: Elsevier Health Sciences; 2011.

2. Nili F, Shams AA. Neonatal complications of premature rupture of Membrane. Acta Med Iran. 2003; 41:175-9.

 3. Kavak SB, Kavak E, Ilhan R, Atilgan R, Arat O, Deveci U, et al. The efficacy of ampicillin and Lactobacillus caseirhamnosus in the active management of preterm premature rupture of membranes remote from term. Drug Des Devel Ther. 2014; 8:1169-73.

 4. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Preterm labor. In: Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J, editors. Williams obstetrics. New York: McGraw-Hill; 2014. P. 836.

5. Mercer BM. Premature rupture of the membranes. In: Creasy RK, Resnik R, editors. Maternal-fetal-medicine. Texas: Gulf Professional Publishing; 2011. P. 663.

 6. Mercer BM. Premature rupture of the membranes. In: Creasy RK, Resnik R, editors. Maternal-fetal-medicine. Texas: Gulf Professional Publishing; 2011. P. 664

 7. Nakubulwa S, Kaye DK, Bwanga F, Tumwesigye NM, Mirembe FM. Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case control study. BMC Res Notes. 2015; 8:573.

 8. Kariman N, Hedayati M, Alavi Majd S. The diagnostic power of cervico-vaginal fluid prolactin in the diagnosis of premature rupture of membranes. Iran Red Crescent Med J. 2012; 14(9):541-8.

 9. Szukiewicz D, Kochanowski J, Mittal TK, Pyzlak M, Szewczyk G, Cendrowski K. Chorioamnionitis (ChA) modifies CX3CL1 (fractalkine) production by human amniotic epithelial cells (HAEC) under normoxic and hypoxic conditions. J Inflamm (Lond). 2014; 11:12.

10. Erdemir G, Kultursay N, Calkavur S, Zekioğlu O, Koroglu OA, Cakmak B, et al. Histological chorioamnionitis: effects on premature delivery and neonatal prognosis. Pediatr Neonatol. 2013; 54(4):267-74.

11. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Preterm labor. In: Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J, editors. Williams obstetrics. New York: McGrawHill; 2014. P. 848.

12. Xie A, Zhang W, Chen M, Wang Y, Wang Y, Zhou Q, et al. Related factors and adverse neonatal outcomes in women with preterm premature rupture of membranes complicated by histologic chorioamnionitis. Med Sci Monit. 2015; 21:390-5.

13. Yousefimanesh H, Robati M, Malekzadeh H, Jahangirnezhad M, Ghafourian Boroujerdnia M, Azadi K. Investigation of the association between salivary procalcitonin concentration and chronic periodontitis. Cell J. 2015; 17(3):559-63.

14. Pieralli F, Vannucchi V, Mancini A, Antonielli E, Luise F, Sammicheli L, et al. Procalcitonin kinetics in the first 72 hours predicts 30-day mortality in severely III septic patients admitted to an intermediate care unit. J Clin Med Res. 2015; 7(9):706-13.

 15. Pantelidou IM, Giamarellos-Bourboulis EJ. Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections? Int J Antimicrob Agents. 2015; 46(Suppl 1):S10-2.

 16. Thornburg LL, Queenan R, Brandt-Griffith B, Pressman EK. Procalcitonin for prediction of chorioamnionitis in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2015; 29(13):2056-61.

 17. Oludag T, Gode F, Caglayan E, Saatli B, Okyay RE, Altunyurt S. Value of maternal procalcitonin levels for predicting subclinical intra-amniotic infection in preterm premature rupture of membranes. J Obstet Gynaecol Res. 2014; 40(4):954-60.

18. Torbé A. Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm. 2007; 2007:35782.

19. Kim SA, Park KH, Lee SM. Non-invasive prediction of histologic chorioamnionitis in women with preterm premature rupture of membranes. Yonsei Med J. 2016; 57(2):461-8.

 20. Ocheke AN, Agaba PA, Imade GE, Silas OA, Ajetunmobi OI, Echejoh G, et al. Chorioamnionitis in pregnancy: a comparative study of HIV-positive and HIV-negative parturients. Int J STD AIDS. 2016; 27(4):296-304.

 21. Altunhan H, Annagür A, Örs R, Mehmetoğlu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis. 2011; 15(12): e854-8.

22. Torbé A. Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm. 2007; 2007:35782.

23. Greksova K, Parrak V, Chovancova D, Stencl P, Oravec J, Marsik L, et al. Procalcitonin, neopterin and C-reactive protein in diagnostics of intrauterine infection and preterm delivery. Bratisl Lek Listy. 2009; 110(10):623-6.

24. Dulay AT, Buhimschi IA, Zhao G, Bahtiyar MO, Thung SF, Cackovic M, et al. Compartmentalization of acute phase reactants Interleukin-6, C-reactive protein and procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis. Cytokine. 2015; 76(2):236-43.

25. Pieralli F, Corbo L, Torrigiani A, Mannini D, Antonielli E, Mancini A, et al. Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit. Intern Emerg Med. 2017; 12(5):629-35.

 26. Ronzino-Dubost V, Sananès N, Lavaux T, Youssef C, Gaudineau A, Lecointre L, et al. Evaluation of the interest of procalcitonin in the diagnosis of chorioamnionitis in preterm premature rupture of membranes. An observational and prospective study. J Gynecol Obstet Biol Reprod (Paris). 2015; 45(7):745-53.

27. Le Ray I, Mace G, Sediki M, Lirussi F, Riethmuller D, Lentz N, et al. Changes in maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study. Am J Reprod Immunol. 2015; 73(1):79-90.

28. Xie AL, DI XD, Chen XM, Hu YC, Wang YH. Factors and neonatal outcomes associated with histologic chorioamnionitis after premature rupture of membranes in the preterms. Zhonghua Fu Chan Ke Za Zhi. 2012; 47(2):105-9.

29. Yoneda S, Shiozaki A, Ito M, Yoneda N, Inada K, Yonezawa R, et al. Accurate prediction of the stage of histological chorioamnionitis before delivery by amniotic fluid IL-8 level. Am J Reprod Immunol. 2015; 73(6):568-76.

 30. Popowski T, Goffinet F, Batteux F, Maillard F, Kayem G. Prediction of maternofetal infection in preterm premature rupture of membranes: serum maternal markers. Gynecol Obstet Fertil. 2011; 39(5):302-8.

 31. Kidokoro K, Furuhashi M, Kuno N, Ishikawa K. Amniotic fluid neutrophil elastase and lactate dehydrogenase: association with histologic chorioamnionitis. Acta Obstet Gynecol Scand. 2006; 85(6):669-74.

32. Myntti T, Rahkonen L, Tikkanen M, Paavonen J, Stefanovic V. Vaginally obtained amniotic fluid samples in the diagnosis of subclinical chorioamnionitis. Acta Obstet Gynecol Scand. 2016; 95(2):233-7.

33. Pappas A, Kendrick DE, Shankaran S, Stoll BJ, Bell EF, Laptook AR, et al. Chorioamnionitis and early childhood outcomes among extremely lowgestational-age neonates. JAMA Pediatr. 2014; 168(2):137-47.

34. Miyazaki K, Furuhashi M, Ishikawa K, Tamakoshi K, Ikeda T, Kusuda S, et al. The effects of antenatal corticosteroids therapy on very preterm infants after chorioamnionitis. Arch Gynecol Obstet. 2014; 289(6):1185-90.

35. Miyazaki K, Furuhashi M, Ishikawa K, Tamakoshi K, Hayashi K, Kai A, et al. Long-term outcomes of antenatal corticosteroids treatment in very preterm infants after chorioamnionitis. Arch Gynecol Obstet. 2015; 292(6):1239-46.

36. Miyazaki K, Furuhashi M, Ishikawa K, Tamakoshi K, Hayashi K, Kai A, et al. Impact of chorioamnionitis on short- and long-term outcomes in very low birth weight preterm infants: the Neonatal Research Network Japan. J Matern Fetal Neonatal Med. 2016; 29(2):331-7.

37. Lee J, Romero R, Kim SM, Chaemsaithong P, Park CW, Park JS, et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016; 29(5):707-20.